Granata Bio’s Chief Regulatory Officer, CMC, Zeb Younes, was featured in the January 2026 issue of Regulatory Rapporteur, a publication of TOPRA, The Organisation for Professionals in Regulatory Affairs. The issue explores how confidence-based, risk-proportionate regulatory pathways can enable innovation across complex products—from brain-computer interfaces to digital CMC—without compromising patient safety. Read more here.
Zeb’s participation in this article supports Granata Bio’s belief that strong manufacturing and regulatory foundations are what make innovation possible.
Zeb Younes, Chief Regulatory Officer, CMC at Granata Bio, featured in the January 2026 issue of Regulatory Rapporteur
Previous
Previous
David Pépin, PhD, Oviva Therapeutics, and Granata Bio featured in Time magazine series on The Age of Longevity
Next
Next